Nyxoah SA (NASDAQ:NYXH) Short Interest Update

Key Points

• Nyxoah SA (NASDAQ: NYXH) experienced a significant increase in short interest, rising by 51.2% in August, reaching a total of 241,900 shares shorted.
• The company reported a loss of ($0.63) earnings per share, missing analyst estimates, alongside a revenue of $1.58 million for the quarter.
• Nyxoah's stock price is currently at $5.93, with a market capitalization of approximately $201.98 million and a fifty-two week trading range between $5.55 and $11.87.

Nyxoah SA (NASDAQ:NYXH - Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 241,900 shares, anincreaseof51.2% from the July 31st total of 160,000 shares. Approximately1.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 87,800 shares, the days-to-cover ratio is presently 2.8 days. Based on an average daily trading volume, of 87,800 shares, the days-to-cover ratio is presently 2.8 days. Approximately1.4% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vestal Point Capital LP acquired a new stake in Nyxoah during the 4th quarter worth about $23,394,000. Shay Capital LLC acquired a new stake in shares of Nyxoah during the second quarter worth approximately $374,000. Kovack Advisors Inc. increased its stake in Nyxoah by 148.2% in the 2nd quarter. Kovack Advisors Inc. now owns 57,827 shares of the company's stock valued at $433,000 after buying an additional 34,532 shares during the period. Ameriprise Financial Inc. acquired a new position in Nyxoah in the 4th quarter valued at approximately $135,000. Finally, Raymond James Financial Inc. purchased a new stake in Nyxoah in the 2nd quarter worth approximately $70,000.

Nyxoah Price Performance

Shares of NASDAQ:NYXH traded up $0.23 on Friday, reaching $5.93. 32,144 shares of the company traded hands, compared to its average volume of 160,054. The stock has a market capitalization of $201.98 million, a PE ratio of -2.58 and a beta of 1.60. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.63 and a quick ratio of 2.38. The company's 50 day moving average is $7.12 and its 200-day moving average is $7.56. Nyxoah has a fifty-two week low of $5.55 and a fifty-two week high of $11.87.

Nyxoah (NASDAQ:NYXH - Get Free Report) last announced its earnings results on Monday, August 18th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.62) by ($0.01). Nyxoah had a negative return on equity of 79.18% and a negative net margin of 1,541.84%.The company had revenue of $1.58 million for the quarter, compared to analyst estimates of $1.33 million. As a group, analysts anticipate that Nyxoah will post -1.91 earnings per share for the current fiscal year.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.